| Brian Shigenobu Furukawa, MD | |
|
2401 S 31st St, Temple, TX 76508-5916 | |
| (254) 724-2111 | |
| Not Available |
| Full Name | Brian Shigenobu Furukawa |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 18 Years |
| Location | 2401 S 31st St, Temple, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457563231 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 140189 (California) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | N7424 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Pavilion - Temple | Temple, TX | Hospital |
| Baylor Scott & White Medical Center - Round Rock | Round rock, TX | Hospital |
| Baylor Scott & White Medical Center - Marble Falls | Marble falls, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
The World Food Programme (WFP) has warned that 1.5 to 2 million more people in Afghanistan likely will be pushed into food insecurity later this year because of ongoing drought in the northern, northeastern and western parts of the country, IRIN reports.
American Medical Systems Holdings, Inc. (NASDAQ: AMMD) (the "Company"), today announced the results of its exchange offer (the "Exchange Offer") in which the Company offered $1,000 principal amount of its newly issued 4.00% Convertible Senior Subordinated Notes due 2041 (the "2041 Notes") in exchange for each $1,000 principal amount of its outstanding 3.25% Convertible Senior Subordinated Notes due 2036 (the "2036 Notes"), for up to $250 million, and no less than $100 million, aggregate principal amount of 2036 Notes.
Acid reflux is thought to be - at most - an irritating condition easily controlled with medication, diet and weight loss.
Two proteins previously found to contribute to ALS, also known as Lou Gehrig's disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them.
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
› Verified 1 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
The World Food Programme (WFP) has warned that 1.5 to 2 million more people in Afghanistan likely will be pushed into food insecurity later this year because of ongoing drought in the northern, northeastern and western parts of the country, IRIN reports.
American Medical Systems Holdings, Inc. (NASDAQ: AMMD) (the "Company"), today announced the results of its exchange offer (the "Exchange Offer") in which the Company offered $1,000 principal amount of its newly issued 4.00% Convertible Senior Subordinated Notes due 2041 (the "2041 Notes") in exchange for each $1,000 principal amount of its outstanding 3.25% Convertible Senior Subordinated Notes due 2036 (the "2036 Notes"), for up to $250 million, and no less than $100 million, aggregate principal amount of 2036 Notes.
Acid reflux is thought to be - at most - an irritating condition easily controlled with medication, diet and weight loss.
Two proteins previously found to contribute to ALS, also known as Lou Gehrig's disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them.
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian Shigenobu Furukawa, MD Po Box 844658, Dallas, TX 75284-4658 Ph: () - | Brian Shigenobu Furukawa, MD 2401 S 31st St, Temple, TX 76508-5916 Ph: (254) 724-2111 |
News Archive
The World Food Programme (WFP) has warned that 1.5 to 2 million more people in Afghanistan likely will be pushed into food insecurity later this year because of ongoing drought in the northern, northeastern and western parts of the country, IRIN reports.
American Medical Systems Holdings, Inc. (NASDAQ: AMMD) (the "Company"), today announced the results of its exchange offer (the "Exchange Offer") in which the Company offered $1,000 principal amount of its newly issued 4.00% Convertible Senior Subordinated Notes due 2041 (the "2041 Notes") in exchange for each $1,000 principal amount of its outstanding 3.25% Convertible Senior Subordinated Notes due 2036 (the "2036 Notes"), for up to $250 million, and no less than $100 million, aggregate principal amount of 2036 Notes.
Acid reflux is thought to be - at most - an irritating condition easily controlled with medication, diet and weight loss.
Two proteins previously found to contribute to ALS, also known as Lou Gehrig's disease, have divergent roles. But a new study, led by researchers at the Department of Cellular and Molecular Medicine at the University of California, San Diego School of Medicine, shows that a common pathway links them.
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
› Verified 1 days ago
Raagsudha Jhavar, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1605 S 31st St, Temple, TX 76508 Phone: 254-215-0100 Fax: 254-215-0636 | |
Dr. John L. Carpenter, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Farrukh Sarmad Badsha, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St # Msa1300, Temple, TX 76508 Phone: 254-935-5820 | |
Dr. Seetha Kannan, M.D Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 2409 Pin Oak Dr, Temple, TX 76502 Phone: 254-774-8060 | |
Jennifer D Moran, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2111 | |
Dr. Douglas Randall Bretzing, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2364 | |
Dr. Patrick Ramirez, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2401 S 31st St, Temple, TX 76508 Phone: 254-724-2364 Fax: 254-724-7603 |